Viridian Therapeutics Correlations
VRDN Stock | USD 15.46 0.20 1.31% |
The current 90-days correlation between Viridian Therapeutics and Day One Biopharmaceuticals is 0.23 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viridian Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viridian Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Viridian Therapeutics Correlation With Market
Average diversification
The correlation between Viridian Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Viridian |
Moving together with Viridian Stock
0.73 | CDIOW | Cardio Diagnostics | PairCorr |
0.79 | ELVN | Enliven Therapeutics | PairCorr |
0.85 | SCLX | Scilex Holding | PairCorr |
0.81 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.61 | CDIO | Cardio Diagnostics | PairCorr |
0.79 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.67 | CAT | Caterpillar | PairCorr |
0.79 | MSFT | Microsoft Aggressive Push | PairCorr |
Moving against Viridian Stock
0.84 | LUCD | Lucid Diagnostics | PairCorr |
0.77 | WM | Waste Management | PairCorr |
0.58 | GE | GE Aerospace | PairCorr |
0.42 | PLX | Protalix Biotherapeutics | PairCorr |
0.41 | PG | Procter Gamble | PairCorr |
0.84 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.81 | T | ATT Inc Sell-off Trend | PairCorr |
0.69 | CVX | Chevron Corp | PairCorr |
0.64 | CSCO | Cisco Systems | PairCorr |
0.63 | INTC | Intel Sell-off Trend | PairCorr |
0.61 | XOM | Exxon Mobil Corp Earnings Call Next Week | PairCorr |
0.58 | IBM | International Business | PairCorr |
0.57 | MMM | 3M Company | PairCorr |
0.41 | DD | Dupont De Nemours | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Viridian Stock performing well and Viridian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viridian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DAWN | 2.87 | (0.52) | 0.00 | (0.64) | 0.00 | 6.36 | 22.86 | |||
REPL | 2.83 | (0.06) | 0.00 | (0.11) | 0.00 | 5.86 | 22.75 | |||
MIRM | 1.87 | 0.25 | 0.11 | 0.16 | 1.99 | 5.32 | 13.96 | |||
RCKT | 2.70 | (0.41) | 0.00 | (0.41) | 0.00 | 4.92 | 12.71 | |||
RNA | 2.83 | 0.07 | 0.00 | (0.02) | 0.00 | 6.64 | 20.15 | |||
QURE | 3.96 | 0.09 | 0.00 | (0.02) | 0.00 | 7.02 | 30.10 | |||
PTGX | 2.79 | 0.42 | 0.22 | (0.35) | 2.47 | 3.48 | 50.66 | |||
PLRX | 6.35 | (1.80) | 0.00 | (0.61) | 0.00 | 10.39 | 80.84 | |||
IMCR | 2.10 | 0.11 | 0.05 | 0.14 | 2.55 | 5.34 | 10.97 | |||
RVMD | 1.71 | (0.16) | 0.00 | (0.20) | 0.00 | 4.37 | 11.35 |
Viridian Therapeutics Corporate Management
Seth Harmon | Principal Accounting | Profile | |
Anthony Casicano | Chief Officer | Profile | |
Kristian MBA | Chief CFO | Profile | |
Melissa Manno | Chief Officer | Profile | |
Anthony Casciano | Chief Officer | Profile | |
Jennifer JD | Chief Officer | Profile |